During the past decade, Centre François Baclesse conducted 267 clinical trials. In the 10-year time frame, 267 clinical trials started and 48 clinical trials were completed, i.e. on average, 18% percent of trials that started reached the finish line to date. In the past 5 years, 121 clinical trials started and 30 clinical trials were completed. i.e. 24.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre François Baclesse" #1 sponsor was "Centre Francois Baclesse" with 85 trials, followed by "UNICANCER" with 82 trials sponsored, "Hoffmann-La Roche" with 26 trials sponsored, "Centre Oscar Lambret" with 22 trials sponsored and "Centre Leon Berard" with 22 trials sponsored. Other sponsors include 255 different institutions and companies that sponsored additional 114 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre François Baclesse" #1 collaborator was "National Cancer Institute, France" with 26 trials as a collaborator, "AstraZeneca" with 18 trials as a collaborator, "Hoffmann-La Roche" with 11 trials as a collaborator, "Merck Sharp & Dohme LLC" with 11 trials as a collaborator and "Roche Pharma AG" with 9 trials as a collaborator. Other collaborators include 344 different institutions and companies that were collaborators in the rest 227 trials.

According to Clinical.Site data, the most researched conditions in "Centre François Baclesse" are "Breast Cancer" (61 trials), "Ovarian Cancer" (21 trials), "Prostate Cancer" (18 trials), "Cancer" (17 trials) and "Head and Neck Cancer" (12 trials). Many other conditions were trialed in "Centre François Baclesse" in a lesser frequency.

Most popular intervention types in "Centre François Baclesse" are "Drug" (332 trials), "Other" (80 trials), "Radiation" (58 trials), "Procedure" (38 trials) and "Biological" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Paclitaxel" (23 trials), "Bevacizumab" (22 trials), "Carboplatin" (18 trials) and "fluorouracil" (16 trials). Other intervention names were less common.

The vast majority of trials in "Centre François Baclesse" are 330 trials for "All" genders, 127 trials for "Female" genders and 37 trials for "Male" genders.

Currently, there are NaN active trials in "Centre François Baclesse". 5 are not yet recruiting, 100 are recruiting, 82 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 232 completed trials in Centre François Baclesse, 1 suspended trials, and 47 terminated clinical trials to date.

Out of the total trials that were conducted in Centre François Baclesse, 24 "Phase 1" clinical trials were conducted, 188 "Phase 2" clinical trials and 175 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 82 trials that are defined as “Not Applicable".

Centre François Baclesse has several departments that took part in Clinical trials: "Centre Francois Baclesse; Urologie Gynecologie" - 3 trials